The role of a mutant CCR5 allele in HIV-1 transmission and disease progression - PubMed (original) (raw)
doi: 10.1038/nm1196-1240.
W A Paxton, S M Wolinsky, A U Neumann, L Zhang, T He, S Kang, D Ceradini, Z Jin, K Yazdanbakhsh, K Kunstman, D Erickson, E Dragon, N R Landau, J Phair, D D Ho, R A Koup
Affiliations
- PMID: 8898752
- DOI: 10.1038/nm1196-1240
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
Y Huang et al. Nat Med. 1996 Nov.
Abstract
A 32-nucleotide deletion (delta 32) within the beta-chemokine receptor 5 (CCR5) gene has been described in subjects who remain uninfected despite extensive exposure to HIV-1. This allele was found to be common in the Caucasian population with a frequency of 0.0808, but was not found in people of African or Asian ancestry. To determine its role in HIV-1 transmission and disease progression, we analyzed the CCRS genotype of 1252 homosexual men enrolled in the Chicago component of the Multicenter AIDS Cohort Study (MACS). No infected participant was found to be homozygous for the delta 32 allele, whereas 3.6% of at-risk but uninfected Caucasian participants were homozygous, showing the highly protective role of this genotype against sexual acquisition of HIV-1. No evidence was found to suggest that heterozygotes were protected against HIV-1 infection, but a limited protective role against disease progression was noted. The delta 32 allele of CCR5 is therefore an important host factor in HIV-1 transmission and pathogenesis.
Comment in
- HIV-1 infection in an individual homozygous for the CCR5 deletion allele.
Biti R, Ffrench R, Young J, Bennetts B, Stewart G, Liang T. Biti R, et al. Nat Med. 1997 Mar;3(3):252-3. doi: 10.1038/nm0397-252. Nat Med. 1997. PMID: 9055842 No abstract available.
Similar articles
- The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
Paxton WA, Kang S, Koup RA. Paxton WA, et al. AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S89-92. AIDS Res Hum Retroviruses. 1998. PMID: 9581891 - Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ. Smith MW, et al. Science. 1997 Aug 15;277(5328):959-65. doi: 10.1126/science.277.5328.959. Science. 1997. PMID: 9252328 - Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.
Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I. Meyer L, et al. AIDS. 1997 Sep;11(11):F73-8. doi: 10.1097/00002030-199711000-00001. AIDS. 1997. PMID: 9302436 - Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
McNicholl JM, Smith DK, Qari SH, Hodge T. McNicholl JM, et al. Emerg Infect Dis. 1997 Jul-Sep;3(3):261-71. doi: 10.3201/eid0303.970302. Emerg Infect Dis. 1997. PMID: 9284370 Free PMC article. Review. - Determinants of protection among HIV‐exposed seronegative persons: an overview.
Lederman MM, Alter G, Daskalakis DC, Rodriguez B, Sieg SF, Hardy G, Cho M, Anthony D, Harding C, Weinberg A, Silverman RH, Douek DC, Margolis L, Goldstein DB, Carrington M, Goedert JJ. Lederman MM, et al. J Infect Dis. 2010 Nov 1;202 Suppl 3(Suppl 3):S333-8. doi: 10.1086/655967. J Infect Dis. 2010. PMID: 20887220 Free PMC article. Review.
Cited by
- Interventions during Early Infection: Opening a Window for an HIV Cure?
Hiner CR, Mueller AL, Su H, Goldstein H. Hiner CR, et al. Viruses. 2024 Oct 9;16(10):1588. doi: 10.3390/v16101588. Viruses. 2024. PMID: 39459922 Free PMC article. Review. - Detecting and quantifying heterogeneity in susceptibility using contact tracing data.
Tuschhoff BM, Kennedy DA. Tuschhoff BM, et al. PLoS Comput Biol. 2024 Jul 29;20(7):e1012310. doi: 10.1371/journal.pcbi.1012310. eCollection 2024 Jul. PLoS Comput Biol. 2024. PMID: 39074159 Free PMC article. - Materials discovery with extreme properties via reinforcement learning-guided combinatorial chemistry.
Kim H, Choi H, Kang D, Lee WB, Na J. Kim H, et al. Chem Sci. 2024 Apr 24;15(21):7908-7925. doi: 10.1039/d3sc05281h. eCollection 2024 May 29. Chem Sci. 2024. PMID: 38817562 Free PMC article. - High-resolution Inference of Multiplexed Anti-HIV Gene Editing using Single-Cell Targeted DNA Sequencing.
Bouzidi MS, Dossani ZY, Benedetto CD, Raymond KA, Desai S, Chavez LR, Betancur P, Pillai SK. Bouzidi MS, et al. bioRxiv [Preprint]. 2024 Aug 22:2024.01.24.576921. doi: 10.1101/2024.01.24.576921. bioRxiv. 2024. PMID: 38328062 Free PMC article. Preprint. - Plasma metabolomics by nuclear magnetic resonance reveals biomarkers and metabolic pathways associated with the control of HIV-1 infection/progression.
Gómez-Archila LG, Palomino-Schätzlein M, Zapata-Builes W, Rugeles MT, Galeano E. Gómez-Archila LG, et al. Front Mol Biosci. 2023 Jun 29;10:1204273. doi: 10.3389/fmolb.2023.1204273. eCollection 2023. Front Mol Biosci. 2023. PMID: 37457832 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous